Table of Contents Author Guidelines Submit a Manuscript
Table of Contents Alerts

To receive news and publication updates for BioMed Research International, enter your email address in the box below.

BioMed Research International
Volume 2014, Article ID 878319, 15 pages
http://dx.doi.org/10.1155/2014/878319
Review Article

Low Temperature Plasma: A Novel Focal Therapy for Localized Prostate Cancer?

Adam M. Hirst,1 Fiona M. Frame,2 Norman J. Maitland,2 and Deborah O’Connell1

1Department of Physics, York Plasma Institute, University of York, Heslington, York YO10 5DD, UK
2YCR Cancer Research Unit, Department of Biology, University of York, Heslington, York YO10 5DD, UK

Received 16 December 2013; Accepted 6 February 2014; Published 13 March 2014

Academic Editor: Giovanni Luca Gravina

Copyright © 2014 Adam M. Hirst et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Li, J. A. Djenaba, A. Soman et al., “Recent trends in prostate cancer incidence by age, cancer stage, and grade, the United States, 2001–2007,” Prostate Cancer, vol. 2012, Article ID 691380, 8 pages, 2012. View at Publisher · View at Google Scholar
  3. H. Lepor, “Pathophysiology, epidemiology, and natural history of benign prostatic hyperplasia,” Reviews in Urology, vol. 6, supplement 9, pp. S3–S10, 2004. View at Google Scholar
  4. J. Ansari, S. A. Hussain, A. Zarkar, J. S. Tanguay, J. Bliss, and J. Glaholm, “Docetaxel chemotherapy for metastatic hormone refractory prostate cancer as first-line palliative chemotherapy and subsequent re-treatment: birmingham experience,” Oncology Reports, vol. 20, no. 4, pp. 891–896, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Chris and O. Sartor, “Abiraterone and increased survival in metastatic prostate cancer,” The New England Journal of Medicine, vol. 364, pp. 1995–2005, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. D. L. Berry, C. M. Moinpour, C. S. Jiang et al., “Quality of life and pain in advanced stage prostate cancer: results of a Southwest Oncology Group randomized trial comparing docetaxel and estramustine to mitoxantrone and prednisone,” Journal of Clinical Oncology, vol. 24, no. 18, pp. 2828–2835, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Bozzini, P. Colin, P. Nevoux et al., “Focal therapy of prostate cancer: energies and procedures,” Urologic Oncology, vol. 31, no. 2, pp. 155–167, 2013. View at Publisher · View at Google Scholar
  8. L. Mearini and M. Porena, “Transrectal high-intensity focused ultrasound for the treatment of prostate cancer: past, present, and future,” Indian Journal of Urology, vol. 26, no. 1, pp. 4–11, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Duchesne, “Localised prostate cancer: current treatment options,” Australian Family Physician, vol. 40, no. 10, pp. 768–771, 2011. View at Google Scholar · View at Scopus
  10. L. Klotz, “Active surveillance versus radical treatment for favorable-risk localized prostate cancer,” Current Treatment Options in Oncology, vol. 7, no. 5, pp. 355–362, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. M. A. Kollmeier and M. J. Zelefsky, “How to select the optimal therapy for early-stage prostate cancer,” Critical Reviews in Oncology/Hematology, vol. 83, no. 2, pp. 225–234, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. J. L. Stanford, Z. Feng, A. S. Hamilton et al., “Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the prostate cancer outcomes study,” Journal of the American Medical Association, vol. 283, no. 3, pp. 354–360, 2000. View at Google Scholar · View at Scopus
  13. M. Bul, R. C. van den Bergh, X. Zhu et al., “Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer,” BJU International, vol. 110, no. 11, pp. 1672–1677, 2012. View at Google Scholar
  14. M. Bul, X. Zhu, R. Valdagni et al., “Active surveillance for low-risk prostate cancer worldwide: the PRIAS study,” European Urology, vol. 63, no. 4, pp. 597–603, 2013. View at Google Scholar
  15. U. Lindner, J. Trachtenberg, and N. Lawrentschuk, “Focal therapy in prostate cancer: modalities, findings and future considerations,” Nature Reviews Urology, vol. 7, no. 10, pp. 562–571, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Kasivisvanathan, M. Emberton, and H. U. Ahmed, “Focal therapy for prostate cancer: rationale and treatment opportunities,” Clinical Oncology, vol. 25, no. 8, pp. 461–473, 2013. View at Google Scholar
  17. S. Eggener, G. Salomon, P. T. Scardino, J. De la Rosette, T. J. Polascik, and S. Brewster, “Focal therapy for prostate cancer: possibilities and limitations,” European Urology, vol. 58, no. 1, pp. 57–64, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Valerio, H. U. Ahmed, M. Emberton et al., “The role of focal therapy in the management of localised prostate cancer: a systematic review,” European Urology, 2013. View at Publisher · View at Google Scholar
  19. R. Bihrle, R. S. Foster, N. T. Sanghvi, J. P. Donohue, and P. J. Hood, “High intensity focused ultrasound for the treatment of benign prostatic hyperplasia: early United States clinical experience,” Journal of Urology, vol. 151, no. 5, pp. 1271–1275, 1994. View at Google Scholar · View at Scopus
  20. S. Madersbacher, M. Pedevilla, L. Vingers, M. Susani, and M. Marberger, “Effect of high-intensity focused ultrasound on human prostate cancer in vivo,” Cancer Research, vol. 55, no. 15, pp. 3346–3351, 1995. View at Google Scholar · View at Scopus
  21. T. Nomura and H. Mimata, “Focal therapy in the management of prostate cancer: an emerging approach for localized prostate cancer,” Advances in Urology, vol. 2012, Article ID 391437, 8 pages, 2012. View at Publisher · View at Google Scholar
  22. E. R. Cordeiro, X. Cathelineau, S. Thüroff et al., “High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer,” BJU International, vol. 110, no. 9, pp. 1228–1242, 2012. View at Google Scholar
  23. G. R. Ter Haar, R. L. Clarke, M. G. Vaughan, and C. R. Hill, “Trackless surgery using focused ultrasound: technique and case report,” Minimally Invasive Therapy, vol. 1, no. 1, pp. 13–19, 1991. View at Google Scholar · View at Scopus
  24. F. Orsi, P. Arnone, W. Chen, and L. Zhang, “High intensity focused ultrasound ablation: a new therapeutic option for solid tumors,” Journal of Cancer Research and Therapeutics, vol. 6, no. 4, pp. 414–420, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Napoli, M. Anzidei, C. De Nunzio et al., “Real-time magnetic resonance-guided high-intensity focused ultrasound focal therapy for localised prostate cancer: preliminary experience,” European Urology, vol. 63, no. 2, pp. 395–398, 2013. View at Google Scholar
  26. S. Madersbacher, C. Kratzik, N. Szabo, M. Susani, L. Vingers, and M. Marberger, “Tissue ablation in benign prostatic hyperplasia with high-intensity focused ultrasound,” European Urology, vol. 23, no. 1, pp. 39–43, 1993. View at Google Scholar · View at Scopus
  27. J. G. Bomers, J. P. Sedelaar, J. O. Barentsz et al., “MRI-guided interventions for the treatment of prostate cancer,” American Journal of Roentgenology, vol. 199, no. 4, pp. 714–720, 2012. View at Google Scholar
  28. A. B. El Fegoun, E. Barret, D. Prapotnich et al., “Focal therapy with high-intensity focused ultrasound for prostate cancer in the elderly. A feasibility study with 10 years follow-up,” International Brazilian Journal of Urology, vol. 37, no. 2, pp. 213–222, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Chaussy and S. Thüroff, “The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection,” Current Urology Reports, vol. 4, no. 3, pp. 248–252, 2003. View at Google Scholar · View at Scopus
  30. G. M. Spencer, D. J. Rubens, and D. J. Roach, “Hypoechoic fat: a sonographic pitfall,” American Journal of Roentgenology, vol. 164, no. 5, pp. 1277–1280, 1995. View at Google Scholar · View at Scopus
  31. M. Sumitomo, J. Asakuma, H. Yoshii et al., “Anterior perirectal fat tissue thickness is a strong predictor of recurrence after high-intensity focused ultrasound for prostate cancer,” International Journal of Urology, vol. 17, no. 9, pp. 776–782, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Liu, L. Y. Wu, J. K. Choi, and C. E. Berkman, “Targeted photodynamic therapy for prostate cancer: inducing apoptosis via activation of the caspase-8/-3 cascade pathway,” International Journal of Oncology, vol. 36, no. 4, pp. 777–784, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. S. B. Brown, E. A. Brown, and I. Walker, “The present and future role of photodynamic therapy in cancer treatment,” The Lancet Oncology, vol. 5, no. 8, pp. 497–508, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. W. M. Sharman, C. M. Allen, and J. E. Van Lier, “Photodynamic therapeutics: basic principles and clinical applications,” Drug Discovery Today, vol. 4, no. 11, pp. 507–517, 1999. View at Publisher · View at Google Scholar · View at Scopus
  35. L.-O. Klotz, K.-D. Kröncke, and H. Sies, “Singlet oxygen-induced signaling effects in mammalian cells,” Photochemical and Photobiological Sciences, vol. 2, no. 2, pp. 88–94, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. L. J. Schiff, W. C. Eisenberg, J. Dziuba, K. Taylor, and S. J. Moore, “Cytotoxic effects of singlet oxygen,” Environmental Health Perspectives, vol. 76, pp. 199–203, 1987. View at Google Scholar · View at Scopus
  37. K. Briviba, L.-O. Klotz, and H. Sies, “Toxic and signaling effects of photochemically or chemically generated singlet oxygen in biological systems,” Biological Chemistry, vol. 378, no. 11, pp. 1259–1265, 1997. View at Google Scholar · View at Scopus
  38. W. M. Sharman, J. E. Van Lier, and C. M. Allen, “Targeted photodynamic therapy via receptor mediated delivery systems,” Advanced Drug Delivery Reviews, vol. 56, no. 1, pp. 53–76, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. A. J. Bullous, C. M. A. Alonso, and R. W. Boyle, “Photosensitiser-antibody conjugates for photodynamic therapy,” Photochemical and Photobiological Sciences, vol. 10, no. 5, pp. 721–750, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. N. L. Oleinick, R. L. Morris, and I. Belichenko, “The role of apoptosis in response to photodynamic therapy: what, where, why, and how,” Photochemical and Photobiological Sciences, vol. 1, no. 1, pp. 1–21, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. C. M. Moore, M. Emberton, and S. G. Bown, “Photodynamic therapy for prostate cancer—an emerging approach for organ-confined disease,” Lasers in Surgery and Medicine, vol. 43, no. 7, pp. 768–775, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. N. Arumainayagam, C. M. Moore, H. U. Ahmed, and M. Emberton, “Photodynamic therapy for focal ablation of the prostate,” World Journal of Urology, vol. 28, no. 5, pp. 571–576, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Lepor, “Vascular targeted photodynamic therapy for localized prostate cancer,” Reviews in Urology, vol. 10, no. 4, pp. 254–261, 2008. View at Google Scholar
  44. A. Zisman, A. J. Pantuck, J. K. Cohen, and A. S. Belldegrun, “Prostate cryoablation using direct transperineal placement of ultrathin probes through a 17-gauge brachytherapy template—technique and preliminary results,” Urology, vol. 58, no. 6, pp. 988–993, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. A. De La Taille, M. C. Benson, E. Bagiella et al., “Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrence,” BJU International, vol. 85, no. 3, pp. 281–286, 2000. View at Publisher · View at Google Scholar · View at Scopus
  46. J. K. Cohen and R. J. Miller, “Thermal protection of urethra during cryosurgery of prostate,” Cryobiology, vol. 31, no. 3, pp. 313–316, 1994. View at Publisher · View at Google Scholar · View at Scopus
  47. P. Derakhshani, S. Neubauer, M. Braun, J. Zumbe, A. Heidenreich, and U. Engelmann, “Cryoablation of localized prostate cancer. Experience in 48 cases, PSA and biopsy results,” European Urology, vol. 34, no. 3, pp. 181–187, 1998. View at Publisher · View at Google Scholar · View at Scopus
  48. J. L. Chin, D. Lim, and M. Abdelhady, “Review of primary and salvage cryoablation for prostate cancer,” Cancer Control, vol. 14, no. 3, pp. 231–237, 2007. View at Google Scholar · View at Scopus
  49. J. I. Izawa, K. Ajam, E. McGuire et al., “Major surgery to manage definitively severe complications of salvage cryotherapy for prostate cancer,” Journal of Urology, vol. 164, no. 6, pp. 1978–1981, 2000. View at Google Scholar · View at Scopus
  50. A. Gangi, G. Tsoumakidou, O. Abdelli et al., “Percutaneous MR-guided cryoablation of prostate cancer: initial experience,” European Radiology, vol. 22, no. 8, pp. 1829–1835, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. D. A. Palacios, M. Miyake, and C. J. Rosser, “Radiosensitization in prostate cancer: mechanisms and targets,” BMC Urology, vol. 13, no. 1, article 4, 2013. View at Google Scholar
  52. H. E. Johns, “The physicist in cancer treatment and detection,” International Journal of Radiation Oncology Biology Physics, vol. 7, no. 6, pp. 801–808, 1981. View at Google Scholar · View at Scopus
  53. I. R. Radford, “Evidence for a general relationship between the induced level of DNA double-strand breakage and cell-killing after X-irradiation of mammalian cells,” International Journal of Radiation Biology, vol. 49, no. 4, pp. 611–620, 1986. View at Google Scholar · View at Scopus
  54. J. F. Ward, “Biochemistry of DNA lesions,” Radiation Research. Supplement, vol. 8, pp. S103–S111, 1985. View at Google Scholar · View at Scopus
  55. Y. M. Cho, Y. S. Kim, M. J. Kang, W. L. Farrar, and E. M. Hurt, “Long-term recovery of irradiated prostate cancer increases cancer stem cells,” Prostate, vol. 72, no. 16, pp. 1746–1756, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. K. Ogawa, Y. Yoshioka, F. Isohashi et al., “Radiotherapy targeting cancer stem cells: current views and future perspectives,” Anticancer Research, vol. 33, no. 3, pp. 747–754, 2013. View at Google Scholar
  57. C. Chargari, C. Moncharmont, A. Lévy et al., “Cancer stem cells, cornerstone of radioresistance and perspectives for radiosensitization: glioblastoma as an example,” Bulletin du Cancerr, vol. 99, no. 12, pp. 1153–1160, 2012. View at Google Scholar
  58. F. M. Frame, D. Pellacani, A. T. Collins et al., “HDAC inhibitor confers radiosensitivity to prostate stem-like cells,” British Journal of Cancer, vol. 109, pp. 3023–3033, 2013. View at Publisher · View at Google Scholar
  59. S. Hummel, E. Simpson, P. Hemingway, M. D. Stevenson, and A. Rees, “Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation,” Health Technology Assessment, vol. 14, no. 47, pp. 1–108, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. P. Kupelian, D. Kuban, H. Thames et al., “Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995,” International Journal of Radiation Oncology Biology Physics, vol. 61, no. 2, pp. 415–419, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. Y. Trada, A. Plank, and J. Martin, “Defining a dose-response relationship for prostate external beam radiotherapy,” Journal of Medical Imaging and Radiation Oncology, vol. 57, no. 2, pp. 237–246, 2013. View at Google Scholar
  62. M. J. Chen, E. Weltman, R. M. Hanriot et al., “Intensity modulated radiotherapy for localized prostate cancer: rigid compliance to dose-volume constraints as a warranty of acceptable toxicity?” Radiation Oncology, vol. 2, no. 1, article 6, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. I. M. Lips, H. Dehnad, C. H. van Gils, A. E. Boeken Kruger, U. A. van der Heide, and M. van Vulpen, “High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker-based position verification: acute and late toxicity in 331 patients,” Radiation Oncology, vol. 3, no. 1, article 15, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. J. S. Jones, “Radiorecurrent prostate cancer: an emerging and largely mismanaged epidemic,” European Urology, vol. 60, no. 3, pp. 411–412, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. B. S. Chera, C. Rodriguez, C. G. Morris et al., “Dosimetric comparison of three different involved nodal irradiation techniques for stage ii hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy,” International Journal of Radiation Oncology Biology Physics, vol. 75, no. 4, pp. 1173–1180, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. J. A. Efstathiou, P. J. Gray, and A. L. Zietman, “Proton beam therapy and localised prostate cancer: current status and controversies,” British Journal of Cancer, vol. 108, no. 6, pp. 1225–1230, 2013. View at Google Scholar
  67. P. J. Gray and J. A. Efstathiou, “Proton beam radiation therapy for prostate cancer-is the hype (and the cost) justified?” Current Urology Reports, vol. 14, no. 3, pp. 199–208, 2013. View at Publisher · View at Google Scholar
  68. N. C. Sheets, G. H. Goldin, A.-M. Meyer et al., “Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer,” Journal of the American Medical Association, vol. 307, no. 15, pp. 1611–1620, 2012. View at Publisher · View at Google Scholar · View at Scopus
  69. J. F. Fowler, “The radiobiology of prostate cancer including new aspects of fractionated radiotherapy,” Acta Oncologica, vol. 44, no. 3, pp. 265–276, 2005. View at Publisher · View at Google Scholar · View at Scopus
  70. C. Oliai, R. Lanciano, B. Sprandio et al., “Stereotactic body radiation therapy for the primary treatment of localized prostate cancer,” Journal of Radiation Oncology, vol. 2, no. 1, pp. 63–70, 2013. View at Google Scholar
  71. D. J. Brenner and E. J. Hall, “Fractionation and protraction for radiotherapy of prostate carcinoma,” International Journal of Radiation Oncology Biology Physics, vol. 43, no. 5, pp. 1095–1101, 1999. View at Publisher · View at Google Scholar · View at Scopus
  72. T. Seisen, S. J. Drouin, V. Phé et al., “Current role of image-guided robotic radiosurgery (Cyberknife) for prostate cancer treatment,” BJU International, vol. 111, no. 5, pp. 761–766, 2013. View at Publisher · View at Google Scholar
  73. D. E. Freeman and C. R. King, “Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes,” Radiation Oncology, vol. 6, no. 1, article 3, 2011. View at Publisher · View at Google Scholar · View at Scopus
  74. Y. Xie, D. Djajaputra, C. R. King, S. Hossain, L. Ma, and L. Xing, “Intrafractional motion of the prostate during hypofractionated radiotherapy,” International Journal of Radiation Oncology Biology Physics, vol. 72, no. 1, pp. 236–246, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. N. C. Townsend, B. J. Huth, W. Ding et al., “Acute toxicity after CyberKnife-delivered hypofractionated radiotherapy for treatment of prostate cancer,” American Journal of Clinical Oncology, vol. 34, no. 1, pp. 6–10, 2011. View at Publisher · View at Google Scholar · View at Scopus
  76. D. S. Park, “Current status of brachytherapy for prostate cancer,” Korean Journal of Urology, vol. 53, no. 11, pp. 743–749, 2012. View at Google Scholar
  77. P. L. Nguyen, A. V. D'Amico, A. K. Lee, and W. W. Suh, “Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature,” Cancer, vol. 110, no. 7, pp. 1417–1428, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. M. I. Koukourakis and S. Touloupidis, “External beam radiotherapy for prostate cancer: current position and trends,” Anticancer Research, vol. 26, no. 1B, pp. 485–494, 2006. View at Google Scholar · View at Scopus
  79. B. Turkbey, P. A. Pinto, and P. L. Choyke, “Imaging techniques for prostate cancer: implications for focal therapy,” Nature Reviews Urology, vol. 6, no. 4, pp. 191–203, 2009. View at Publisher · View at Google Scholar · View at Scopus
  80. A. H. Hou, D. Swanson, and A. B. Barqawi, “Modalities for imaging of prostate cancer,” Advances in Urology, vol. 2009, Article ID 818065, 12 pages, 2009. View at Publisher · View at Google Scholar · View at Scopus
  81. H. Hricak, P. L. Choyke, S. C. Eberhardt, S. A. Leibel, and P. T. Scardino, “Imaging prostate cancer: a multidisciplinary perspective,” Radiology, vol. 243, no. 1, pp. 28–53, 2007. View at Publisher · View at Google Scholar · View at Scopus
  82. A. Abdellaoui, S. Iyengar, and S. Freeman, “Imaging in prostate cancer,” Future Oncology, vol. 7, no. 5, pp. 679–691, 2011. View at Publisher · View at Google Scholar · View at Scopus
  83. E. J. Halpern, “Contrast-enhanced ultrasound imaging of prostate cancer,” Reviews in Urology, vol. 8, supplement 1, pp. S29–S37, 2006. View at Google Scholar
  84. M. Mitterberger, W. Horninger, F. Aigner et al., “Ultrasound of the prostate,” Cancer Imaging, vol. 10, pp. 40–48, 2010. View at Google Scholar
  85. J. G. Bomers, D. Yakar, C. G. Overduin et al., “MR imaging-guided focal cryoablation in patients with recurrent prostate cancer,” Radiology, vol. 268, no. 2, pp. 451–460, 2013. View at Publisher · View at Google Scholar
  86. A. Oto, I. Sethi, G. Karczmar et al., “MR imaging-guided focal laser ablation for prostate cancer: phase I trial,” Radiology, vol. 267, no. 3, pp. 932–940, 2013. View at Publisher · View at Google Scholar
  87. M. Seitz, A. Shukla-Dave, A. Bjartell et al., “Functional magnetic resonance imaging in prostate cancer,” European Urology, vol. 55, no. 4, pp. 801–814, 2009. View at Google Scholar
  88. F. Cornud, N. B. Delongchamps, P. Mozer et al., “Value of multiparametric MRI in the work-up of prostate cancer,” Current Urology Reports, vol. 13, no. 1, pp. 82–92, 2012. View at Publisher · View at Google Scholar · View at Scopus
  89. A. Shukla-Dave and H. Hricak, “Role of MRI in prostate cancer detection,” NMR in Biomedicine, vol. 27, no. 1, pp. 16–24, 2014. View at Publisher · View at Google Scholar
  90. D. G. Engehausen, K. Engelhard, S. A. Schwab et al., “Magnetic resonance image-guided biopsies with a high detection rate of prostate cancer,” The Scientific World Journal, vol. 2012, Article ID 975971, 6 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  91. G. Fiard, N. Hohn, J. L. Descotes et al., “Targeted MRI-guided prostate biopsies for the detection of prostate cancer: initial clinical experience with real-time 3-dimensional transrectal ultrasound guidance and magnetic resonance/transrectal ultrasound image fusion,” Urology, vol. 81, no. 6, pp. 1372–1378, 2013. View at Publisher · View at Google Scholar
  92. A. Krieger, S.-E. Song, N. Bongjoon Cho et al., “Development and evaluation of an actuated MRI-compatible robotic system for MRI-guided prostate intervention,” IEEE/ASME Transactions on Mechatronics, vol. 18, no. 1, pp. 273–284, 2013. View at Publisher · View at Google Scholar · View at Scopus
  93. F. Pinto, A. Totaro, A. Calarco et al., “Imaging in prostate cancer diagnosis: present role and future perspectives,” Urologia Internationalis, vol. 86, no. 4, pp. 373–382, 2011. View at Publisher · View at Google Scholar · View at Scopus
  94. G. Fridman, M. Peddinghaus, H. Ayan et al., “Blood coagulation and living tissue sterilization by floating-electrode dielectric barrier discharge in air,” Plasma Chemistry and Plasma Processing, vol. 26, no. 4, pp. 425–442, 2006. View at Publisher · View at Google Scholar · View at Scopus
  95. G. Daeschlein, S. Scholz, R. Ahmed et al., “Skin decontamination by low-temperature atmospheric pressure plasma jet and dielectric barrier discharge plasma,” Journal of Hospital Infection, vol. 81, no. 3, pp. 177–183, 2012. View at Google Scholar
  96. M. G. Kong, “A complementary sterilisation strategy using cold atmospheric plasmas,” Medical Device Technology, vol. 17, no. 3, pp. 26–28, 2006. View at Google Scholar · View at Scopus
  97. M. G. Kong, “Cold atmospheric plasma destruction of solid proteins on stainless-steel surface and on real surgical instruments,” GMS Krankenhaushygiene Interdisziplinär, vol. 3, no. 1, Article ID Doc07, 2008. View at Google Scholar
  98. K. Y. Baik, Y. H. Kim, Y. Hyo et al., “Feeding-gas effects of plasma jets on escherichia coli in physiological solutions,” Plasma Processes and Polymers, vol. 10, no. 3, pp. 235–242, 2013. View at Google Scholar
  99. M. Laroussi, C. Tendero, X. Lu, S. Alla, and W. L. Hynes, “Inactivation of bacteria by the plasma pencil,” Plasma Processes and Polymers, vol. 3, no. 6-7, pp. 470–473, 2006. View at Publisher · View at Google Scholar · View at Scopus
  100. K. Fricke, I. Koban, H. Tresp et al., “Atmospheric pressure plasma: a high-performance tool for the efficient removal of biofilms,” PLoS ONE, vol. 7, no. 8, Article ID e42539, 2012. View at Google Scholar
  101. M. Y. Alkawareek, Q. T. Algwari, S. P. Gorman et al., “Application of atmospheric pressure nonthermal plasma for the in vitro eradication of bacterial biofilms,” Fems Immunology and Medical Microbiology, vol. 65, no. 2, pp. 381–384, 2012. View at Google Scholar
  102. J. J. Cotter, P. Maguire, F. Soberon, S. Daniels, J. P. O'Gara, and E. Casey, “Disinfection of meticillin-resistant Staphylococcus aureus and Staphylococcus epidermidis biofilms using a remote non-thermal gas plasma,” Journal of Hospital Infection, vol. 78, no. 3, pp. 204–207, 2011. View at Publisher · View at Google Scholar · View at Scopus
  103. D. Ziuzina, S. Patil, P. J. Cullen et al., “Atmospheric cold plasma inactivation of Escherichia coli in liquid media inside a sealed package,” Journal of Applied Microbiology, vol. 114, no. 3, pp. 778–787, 2013. View at Google Scholar
  104. A. Fernandez, E. Noriega, and A. Thompson, “Inactivation of Salmonella enterica serovar Typhimurium on fresh produce by cold atmospheric gas plasma technology,” Food Microbiology, vol. 33, no. 1, pp. 24–29, 2013. View at Google Scholar
  105. M. Laroussi, “Nonthermal decontamination of biological media by atmospheric-pressure plasmas: review, analysis, and prospects,” IEEE Transactions on Plasma Science, vol. 30, no. 4, pp. 1409–1415, 2002. View at Publisher · View at Google Scholar · View at Scopus
  106. E. Garcia-Alcantara, R. López-Callejas, P. R. Morales-Ramírez et al., “In vivo accelerated acute wound healing in mouse skin using combined treatment of argon and helium plasma needle,” Archives of Medical Research, vol. 44, no. 3, pp. 169–177, 2013. View at Google Scholar
  107. A. S. Wu, S. Kalghatgi, D. Dobrynin et al., “Porcine intact and wounded skin responses to atmospheric nonthermal plasma,” Journal of Surgical Research, vol. 179, no. 1, pp. e1–e12, 2013. View at Google Scholar
  108. R. Sensenig, S. Kalghatgi, E. Cerchar et al., “Non-thermal plasma induces apoptosis in melanoma cells via production of intracellular reactive oxygen species,” Annals of Biomedical Engineering, vol. 39, no. 2, pp. 674–687, 2011. View at Publisher · View at Google Scholar · View at Scopus
  109. X. Yan, Z. Xiong, F. Zou et al., “Plasma-induced death of HepG2 cancer cells: intracellular effects of reactive species,” Plasma Processes and Polymers, vol. 9, no. 1, pp. 59–66, 2012. View at Publisher · View at Google Scholar · View at Scopus
  110. J. Y. Kim, J. Ballato, P. Foy et al., “Apoptosis of lung carcinoma cells induced by a flexible optical fiber-based cold microplasma,” Biosensors and Bioelectronics, vol. 28, no. 1, pp. 333–338, 2011. View at Publisher · View at Google Scholar · View at Scopus
  111. N. K. Kaushik, Y. H. Kim, Y. G. Han et al., “Effect of jet plasma on T98G human brain cancer cells,” Current Applied Physics, vol. 13, no. 1, pp. 176–180, 2013. View at Google Scholar
  112. J. Waskoenig, K. Niemi, N. Knake et al., “Atomic oxygen formation in a radio-frequency driven micro-atmospheric pressure plasma jet,” Plasma Sources Science and Technology, vol. 19, no. 4, Article ID 045018, 2010. View at Google Scholar
  113. N. Knake, K. Niemi, S. Reuter, V. Schulz-von der Gathen, and J. Winter, “Absolute atomic oxygen density profiles in the discharge core of a microscale atmospheric pressure plasma jet,” Applied Physics Letters, vol. 93, no. 13, Article ID 131503, 2008. View at Publisher · View at Google Scholar · View at Scopus
  114. N. Knake and V. Schulz-von der Gathen, “Investigations of the spatio-temporal build-up of atomic oxygen inside the micro-scaled atmospheric pressure plasma jet,” European Physical Journal D, vol. 60, no. 3, pp. 645–652, 2010. View at Publisher · View at Google Scholar · View at Scopus
  115. D. Maletic, N. Puac, S. Lazović et al., “Detection of atomic oxygen and nitrogen created in a radio-frequency-driven micro-scale atmospheric pressure plasma jet using mass spectrometry,” Plasma Physics and Controlled Fusion, vol. 54, no. 12, 2012. View at Google Scholar
  116. L. Packer and H. Sies, Eds., Methods in Enzymology, Singlet Oxygen, UV-A and Ozone, vol. 319, Academic Press, New York, NY, USA, 2000.
  117. H. Wiseman and B. Halliwell, “Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer,” Biochemical Journal, vol. 313, no. 1, pp. 17–29, 1996. View at Google Scholar · View at Scopus
  118. H. Sies, “Oxidative stress: oxidants and antioxidants,” Experimental Physiology, vol. 82, no. 2, pp. 291–295, 1997. View at Google Scholar · View at Scopus
  119. U. Bandyopadhyay, D. Das, and R. K. Banerjee, “Reactive oxygen species: oxidative damage and pathogenesis,” Current Science, vol. 77, no. 5, pp. 658–666, 1999. View at Google Scholar · View at Scopus
  120. D. B. Graves, “The emerging role of reactive oxygen and nitrogen species in redox biology and some implications for plasma applications to medicine and biology,” Journal of Physics D, vol. 45, no. 26, 2012. View at Google Scholar
  121. M. Laroussi, Plasma Medicine: Applications of Low-Temperature Gas Plasmas in Medicine and Biology, Cambridge University Press, Cambridge, UK, 2012.
  122. J. Jaroslav, Q. T. Algwari, D. O'Connell et al., “Experimental-modeling study of an atmospheric-pressure helium discharge propagating in a thin dielectric tube,” Ieee Transactions on Plasma Science, vol. 40, no. 11, pp. 2912–2919, 2012. View at Google Scholar
  123. Q. T. Algwari and D. O'Connell, “Electron dynamics and plasma jet formation in a helium atmospheric pressure dielectric barrier discharge jet,” Applied Physics Letters, vol. 99, no. 12, Article ID 121501, 2011. View at Publisher · View at Google Scholar · View at Scopus
  124. J. L. Walsh and M. G. Kong, “Contrasting characteristics of linear-field and cross-field atmospheric plasma jets,” Applied Physics Letters, vol. 93, no. 11, Article ID 111501, 2008. View at Publisher · View at Google Scholar · View at Scopus
  125. D. U. Silverthorn and B. R. Johnson, HumAn Physiology: An Integrated Approach, Pearson Education, San Francisco, Calif, USA, 3rd edition, 2004, contributions by Bruce R. Johnson.
  126. T. Murakami, K. Niemi, T. Gans et al., “Chemical kinetics and reactive species in atmospheric pressure helium-oxygen plasmas with humid-air impurities,” Plasma Sources Science & Technology, vol. 22, no. 1, 2013. View at Google Scholar
  127. E. Wagenaars, T. Gans, D. O'Connell, and K. Niemi, “Two-photon absorption laser-induced fluorescence measurements of atomic nitrogen in a radio-frequency atmospheric-pressure plasma jet,” Plasma Sources Science & Technology, vol. 21, no. 4, 2012. View at Google Scholar
  128. K. Niemi, J. Waskoenig, N. Sadeghi, T. Gans, and D. O'Connell, “The role of helium metastable states in radio-frequency driven helium-oxygen atmospheric pressure plasma jets: measurement and numerical simulation,” Plasma Sources Science and Technology, vol. 20, no. 5, Article ID 055005, 2011. View at Publisher · View at Google Scholar · View at Scopus
  129. C. O'Neill, J. Waskoenig, and T. Gans, “Tailoring electron energy distribution functions through energy confinement in dual radio-frequency driven atmospheric pressure plasmas,” Applied Physics Letters, vol. 101, no. 15, pp. 154107–154104, 2012. View at Google Scholar
  130. T. Murakami, K. Niemi, T. Gans, D. O'Connell, and W. G. Graham, “Afterglow chemistry of atmospheric-pressure helium-oxygen plasmas with humid air impurity,” Plasma Sources Science and Technology, vol. 23, no. 2, Article ID 025005, 2014. View at Google Scholar
  131. K. Niemi, D. O'Connell, N. de Oliveira et al., “Absolute atomic oxygen and nitrogen densities in radio-frequency driven atmospheric pressure cold plasmas: synchrotron vacuum ultra-violet high-resolution Fourier-transform absorption measurements,” Applied Physics Letters, vol. 103, no. 3, Article ID 034102, 2013. View at Google Scholar
  132. J. Waskoenig and T. Gans, “Nonlinear frequency coupling in dual radio-frequency driven atmospheric pressure plasmas,” Applied Physics Letters, vol. 96, no. 18, Article ID 181501, 2010. View at Publisher · View at Google Scholar · View at Scopus
  133. K. Niemi, S. Reuter, L. M. Graham et al., “Diagnostic based modelling of radio-frequency driven atmospheric pressure plasmas,” Journal of Physics D, vol. 43, no. 12, Article ID 124006, 2010. View at Publisher · View at Google Scholar · View at Scopus
  134. K. Niemi, S. Reuter, L. M. Graham, J. Waskoenig, and T. Gans, “Diagnostic based modeling for determining absolute atomic oxygen densities in atmospheric pressure helium-oxygen plasmas,” Applied Physics Letters, vol. 95, no. 15, Article ID 151504, 2009. View at Publisher · View at Google Scholar · View at Scopus
  135. V. Schulz-von der Gathen, L. Schaper, N. Knake et al., “Spatially resolved diagnostics on a microscale atmospheric pressure plasma jet,” Journal of Physics D, vol. 41, no. 19, Article ID 194004, 2008. View at Publisher · View at Google Scholar · View at Scopus
  136. D. Ellerweg, J. Benedikt, A. Von Keudell, N. Knake, and V. Schulz-von der Gathen, “Characterization of the effluent of a He/O2 microscale atmospheric pressure plasma jet by quantitative molecular beam mass spectrometry,” New Journal of Physics, vol. 12, Article ID 013021, 2010. View at Publisher · View at Google Scholar · View at Scopus
  137. G. E. Morfill, M. G. Kong, and J. L. Zimmermann, “Focus on plasma medicine,” New Journal of Physics, vol. 11, Article ID 115011, 2009. View at Publisher · View at Google Scholar · View at Scopus
  138. M. Laroussi and F. Leipold, “Evaluation of the roles of reactive species, heat, and UV radiation in the inactivation of bacterial cells by air plasmas at atmospheric pressure,” International Journal of Mass Spectrometry, vol. 233, no. 1–3, pp. 81–86, 2004. View at Publisher · View at Google Scholar · View at Scopus
  139. G. Fridman, A. D. Brooks, M. Balasubramanian et al., “Comparison of direct and indirect effects of non-thermal atmospheric-pressure plasma on bacteria,” Plasma Processes and Polymers, vol. 4, no. 4, pp. 370–375, 2007. View at Publisher · View at Google Scholar · View at Scopus
  140. R. E. J. Sladek and E. Stoffels, “Deactivation of Escherichia coli by the plasma needle,” Journal of Physics D, vol. 38, no. 11, pp. 1716–1721, 2005. View at Publisher · View at Google Scholar · View at Scopus
  141. S. Perni, G. Shama, J. L. Hobman et al., “Probing bactericidal mechanisms induced by cold atmospheric plasmas with Escherichia coli mutants,” Applied Physics Letters, vol. 90, no. 7, Article ID 073902, 2007. View at Publisher · View at Google Scholar · View at Scopus
  142. M. Moisan, J. Barbeau, S. Moreau, J. Pelletier, M. Tabrizian, and L. Yahia, “Low-temperature sterilization using gas plasmas: a review of the experiments and an analysis of the inactivation mechanisms,” International Journal of Pharmaceutics, vol. 226, no. 1-2, pp. 1–21, 2001. View at Publisher · View at Google Scholar · View at Scopus
  143. Z. L. Petrović, S. Puač, N. Lazović et al., “Biomedical applications and diagnostics of atmospheric pressure plasma,” Journal of Physics, vol. 356, no. 1, Article ID 012001, 2012. View at Google Scholar
  144. M. Y. Alkawareek, Q. Th. Algwari, G. Laverty et al., “Eradication of Pseudomonas aeruginosa biofilms by atmospheric pressure non-thermal plasma,” PLoS ONE, vol. 7, no. 8, Article ID e44289, 2012. View at Google Scholar
  145. E. Stoffels, R. E. J. Sladek, and I. E. Kieft, “Gas plasma effects on living cells,” Physica Scripta, vol. 2004, article 79, 2004. View at Google Scholar
  146. C. Jiang, M.-T. Chen, A. Gorur et al., “Nanosecond pulsed plasma dental probe,” Plasma Processes and Polymers, vol. 6, no. 8, pp. 479–483, 2009. View at Publisher · View at Google Scholar · View at Scopus
  147. G. Isbary, G. Morfill, H. U. Schmidt et al., “A first prospective randomized controlled trial to decrease bacterial load using cold atmospheric argon plasma on chronic wounds in patients,” British Journal of Dermatology, vol. 163, no. 1, pp. 78–82, 2010. View at Publisher · View at Google Scholar · View at Scopus
  148. G. Isbary, J. Heinlin, T. Shimizu et al., “Successful and safe use of 2 min cold atmospheric argon plasma in chronic wounds: results of a randomized controlled trial,” British Journal of Dermatology, vol. 167, no. 2, pp. 404–410, 2012. View at Google Scholar
  149. G. Daeschlein, S. Scholz, R. Ahmed et al., “Cold plasma is well-tolerated and does not disturb skin barrier or reduce skin moisture,” Journal der Deutschen Dermatologischen Gesellschaft, vol. 10, no. 7, pp. 509–515, 2012. View at Google Scholar
  150. M. B. Witte and A. Barbul, “Role of nitric oxide in wound repair,” American Journal of Surgery, vol. 183, no. 4, pp. 406–412, 2002. View at Publisher · View at Google Scholar · View at Scopus
  151. A. Soneja, M. Drews, and T. Malinski, “Role of nitric oxide, nitroxidative and oxidative stress in wound healing,” Pharmacological Reports, vol. 57, pp. 108–119, 2005. View at Google Scholar · View at Scopus
  152. G. Fridman, G. Friedman, A. Gutsol, A. B. Shekhter, V. N. Vasilets, and A. Fridman, “Applied plasma medicine,” Plasma Processes and Polymers, vol. 5, no. 6, pp. 503–533, 2008. View at Publisher · View at Google Scholar · View at Scopus
  153. G. Lloyd, G. Friedman, S. Jafri, G. Schultz, A. Fridman, and K. Harding, “Gas plasma: medical uses and developments in wound care,” Plasma Processes and Polymers, vol. 7, no. 3-4, pp. 194–211, 2010. View at Publisher · View at Google Scholar · View at Scopus
  154. J. Heinlin, G. Morfill, M. Landthaler et al., “Plasma medicine: possible applications in dermatology,” Journal der Deutschen Dermatologischen Gesellschaft, vol. 8, no. 12, pp. 968–976, 2010. View at Google Scholar
  155. K. R. Stalder, D. F. McMillen, and J. Woloszko, “Electrosurgical plasmas,” Journal of Physics D, vol. 38, no. 11, pp. 1728–1738, 2005. View at Publisher · View at Google Scholar · View at Scopus
  156. J. Raiser and M. Zenker, “Argon plasma coagulation for open surgical and endoscopic applications: state of the art,” Journal of Physics D, vol. 39, no. 16, Article ID 3520, 2006. View at Publisher · View at Google Scholar · View at Scopus
  157. J. M. Canard and B. Védrenne, “Clinical application of argon plasma coagulation in gastrointestinal endoscopy: has the time come to replace the laser?” Endoscopy, vol. 33, no. 4, pp. 353–357, 2001. View at Publisher · View at Google Scholar · View at Scopus
  158. B. Geavlete, R. Multescu, M. Dragutescu, M. Jecu, D. Georgescu, and P. Geavlete, “Transurethral resection (TUR) in saline plasma vaporization of the prostate vs standard TUR of the prostate: “The better choice” in benign prostatic hyperplasia?” BJU International, vol. 106, no. 11, pp. 1695–1699, 2010. View at Publisher · View at Google Scholar · View at Scopus
  159. L. P. Xie, J. Qin, X. Y. Zheng et al., “Transurethral vapor enucleation and resection of prostate with TURis button electrode,” Zhonghua Yi Xue Za Zhi, vol. 92, no. 22, pp. 1558–1559, 2012. View at Google Scholar
  160. S. Y. Zhang, H. Hu, X. P. Zhang et al., “Efficacy and safety of bipolar plasma vaporization of the prostate with, “button-type” electrode compared with transurethral resection of prostate for benign prostatic hyperplasia,” Chinese Medical Journal, vol. 125, no. 21, pp. 3811–3814, 2012. View at Google Scholar
  161. G. Fridman, A. Shereshevsky, M. M. Jost et al., “Floating electrode dielectric barrier discharge plasma in air promoting apoptotic behavior in Melanoma skin cancer cell lines,” Plasma Chemistry and Plasma Processing, vol. 27, no. 2, pp. 163–176, 2007. View at Publisher · View at Google Scholar · View at Scopus
  162. G.-C. Kim, H. J. Lee, and C.-H. Shon, “The effects of a micro plasma on melanoma (G361) cancer cells,” Journal of the Korean Physical Society, vol. 54, no. 2, pp. 628–632, 2009. View at Publisher · View at Google Scholar · View at Scopus
  163. S. Arndt, E. Wacker, Y. F. Li et al., “Cold atmospheric plasma, a new strategy to induce senescence in melanoma cells,” Experimental Dermatology, vol. 22, no. 4, pp. 284–289, 2013. View at Google Scholar
  164. S. Iseki, K. Nakamura, M. Hayashi et al., “Selective killing of ovarian cancer cells through induction of apoptosis by nonequilibrium atmospheric pressure plasma,” Applied Physics Letters, vol. 100, no. 11, Article ID 113702, 2012. View at Publisher · View at Google Scholar · View at Scopus
  165. C.-H. Kim, S. Kwon, J. H. Bahn et al., “Effects of atmospheric nonthermal plasma on invasion of colorectal cancer cells,” Applied Physics Letters, vol. 96, no. 24, Article ID 243701, 2010. View at Publisher · View at Google Scholar · View at Scopus
  166. X. Zhang, M. Li, R. Zhou, K. Feng, and S. Yang, “Ablation of liver cancer cells in vitro by a plasma needle,” Applied Physics Letters, vol. 93, no. 2, Article ID 021502, 2008. View at Publisher · View at Google Scholar · View at Scopus
  167. M. Wang, B. Holmes, X. Cheng et al., “Cold atmospheric plasma for selectively ablating metastatic breast cancer cells,” PLoS ONE, vol. 8, no. 9, Article ID e73741, 2013. View at Google Scholar
  168. N. K. Kaushik, P. Attriemail, N. Kaushikemail et al., “A preliminary study of the effect of DBD plasma and osmolytes on T98G brain cancer and HEK non-malignant cells,” Molecules, vol. 18, no. 5, pp. 4917–4928, 2013. View at Google Scholar
  169. D. O'Connell, L. J. Cox, W. B. Hyland et al., “Cold atmospheric pressure plasma jet interactions with plasmid DNA,” Applied Physics Letters, vol. 98, no. 4, Article ID 043701, 2011. View at Publisher · View at Google Scholar · View at Scopus
  170. I. E. Kieft, M. Kurdi, and E. Stoffels, “Reattachment and apoptosis after plasma-needle treatment of cultured cells,” IEEE Transactions on Plasma Science, vol. 34, no. 4, pp. 1331–1336, 2006. View at Publisher · View at Google Scholar · View at Scopus
  171. N. Barekzi and M. Laroussi, “Dose-dependent killing of leukemia cells by low-temperature plasma,” Journal of Physics D, vol. 45, no. 42, 2012. View at Google Scholar
  172. M. Vandamme, E. Robert, S. Dozias et al., “Response of human glioma U87 xenografted on mice to non thermal plasma treatment,” Plasma Medicine, vol. 1, no. 1, pp. 27–43, 2011. View at Publisher · View at Google Scholar · View at Scopus
  173. O. Volotskova, T. S. Hawley, M. A. Stepp et al., “Targeting the cancer cell cycle by cold atmospheric plasma,” Scientific Reports, vol. 2, article 636, 2012. View at Google Scholar
  174. M. Vandamme, E. Robert, S. Lerondel et al., “ROS implication in a new antitumor strategy based on non-thermal plasma,” International Journal of Cancer, vol. 130, no. 9, pp. 2185–2194, 2012. View at Publisher · View at Google Scholar · View at Scopus
  175. G. J. Kim, W. Kim, K. T. Kim, and J. K. Lee, “DNA damage and mitochondria dysfunction in cell apoptosis induced by nonthermal air plasma,” Applied Physics Letters, vol. 96, no. 2, Article ID 021502, 2010. View at Publisher · View at Google Scholar · View at Scopus
  176. M. Thiyagarajan, X. F. Gonzales, and H. Anderson, “Regulated cellular exposure to non-thermal plasma allows preferentially directed apoptosis in acute monocytic leukemia cells,” Studies in Health Technology and Informatics, vol. 184, pp. 436–442, 2013. View at Google Scholar
  177. R. M. Walk, J. A. Snyder, P. Srinivasan et al., “Cold atmospheric plasma for the ablative treatment of neuroblastoma,” Journal of Pediatric Surgery, vol. 48, no. 1, pp. 67–73, 2013. View at Google Scholar
  178. J. T. Au, T. P. Kingham, K. Jun et al., “Irreversible electroporation ablation of the liver can be detected with ultrasound B-mode and elastography,” Surgery, vol. 153, no. 6, pp. 787–793, 2013. View at Publisher · View at Google Scholar
  179. J. Fanta, P. Hora'k, J. Marvan et al., “The NanoKnife and two successful cases of intracavitary irreversible electroporation of main bronchus tumours,” Rozhledy v Chirurgii, vol. 91, no. 11, pp. 625–630, 2012. View at Google Scholar
  180. G. Onik, P. Mikus, and B. Rubinsky, “Irreversible electroporation: implications for prostate ablation,” Technology in Cancer Research and Treatment, vol. 6, no. 4, pp. 295–300, 2007. View at Google Scholar · View at Scopus
  181. L. Brulle, M. Vandamme, D. Riès et al., “Effects of a non thermal plasma treatment alone or in combination with gemcitabine in a MIA PaCa2-luc orthotopic pancreatic carcinoma model,” PLoS ONE, vol. 7, no. 12, Article ID e52653, 2012. View at Google Scholar
  182. D. Dobrynin, G. Fridman, G. Friedman, and A. Fridman, “Physical and biological mechanisms of direct plasma interaction with living tissue,” New Journal of Physics, vol. 11, Article ID 115020, 2009. View at Publisher · View at Google Scholar · View at Scopus
  183. S. Kalghatgi, G. Friedman, A. Fridman, and A. M. Clyne, “Endothelial cell proliferation is enhanced by low dose non-thermal plasma through fibroblast growth factor-2 release,” Annals of Biomedical Engineering, vol. 38, no. 3, pp. 748–757, 2010. View at Publisher · View at Google Scholar · View at Scopus
  184. D. Hirst and T. Robson, “Targeting nitric oxide for cancer therapy,” Journal of Pharmacy and Pharmacology, vol. 59, no. 1, pp. 3–13, 2007. View at Publisher · View at Google Scholar · View at Scopus
  185. D. J. Stuehr and C. F. Nathan, “Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells,” Journal of Experimental Medicine, vol. 169, no. 5, pp. 1543–1555, 1989. View at Google Scholar · View at Scopus
  186. A. Korkmaz, S. Oter, M. Seyrek et al., “Molecular, genetic and epigenetic pathways of peroxynitrite-induced cellular toxicity,” Interdisciplinary Toxicology, vol. 2, no. 4, pp. 219–228, 2009. View at Google Scholar
  187. J. Fraszczak, M. Trad, N. Janikashvili et al., “Peroxynitrite-dependent killing of cancer cells and presentation of released tumor antigens by activated dendritic cells,” Journal of Immunology, vol. 184, no. 4, pp. 1876–1884, 2010. View at Publisher · View at Google Scholar · View at Scopus
  188. J. S. Sousa, K. Niemi, L. J. Cox, Q. T. Algwari, T. Gans, and D. O'Connell, “Cold atmospheric pressure plasma jets as sources of singlet delta oxygen for biomedical applications,” Journal of Applied Physics, vol. 109, no. 12, Article ID 123302, 2011. View at Publisher · View at Google Scholar · View at Scopus
  189. V. Puech, G. Bauville, B. Lacour et al., “Micro-plasmas as efficient generators of singlet delta oxygen—art. no. 700527,” High-Power Laser Ablation Vii, Pts 1-2, vol. 7005, article 527, 2008. View at Google Scholar
  190. A. A. Ionin, I. V. Kochetov, A. P. Napartovich, and N. N. Yuryshev, “Physics and engineering of singlet delta oxygen production in low-temperature plasma,” Journal of Physics D, vol. 40, no. 2, article R01, pp. R25–R61, 2007. View at Publisher · View at Google Scholar · View at Scopus
  191. M. Keidar, R. Walk, A. Shashurin et al., “Cold plasma selectivity and the possibility of a paradigm shift in cancer therapy,” British Journal of Cancer, vol. 105, no. 9, pp. 1295–1301, 2011. View at Publisher · View at Google Scholar · View at Scopus
  192. G. J. Kim, S. R. Park, G. C. Kim, and J. K. Lee, “Targeted cancer treatment using anti-EGFR and -TFR antibody-conjugated gold nanoparticles stimulated by nonthermal air plasma,” Plasma Medicine, vol. 1, no. 1, pp. 45–54, 2011. View at Publisher · View at Google Scholar · View at Scopus
  193. M. Keidar, A. Shashurin, O. Volotskova et al., “Cold atmospheric plasma in cancer therapy,” Physics of Plasmas, vol. 20, no. 5, Article ID 057101, 8 pages, 2013. View at Google Scholar
  194. H. U. Ahmed, R. G. Hindley, L. Dickinson et al., “Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study,” The Lancet Oncology, vol. 13, no. 6, pp. 622–632, 2012. View at Publisher · View at Google Scholar · View at Scopus
  195. L. Klotz, “Active surveillance: patient selection,” Current Opinion in Urology, vol. 23, no. 3, pp. 239–244, 2013. View at Google Scholar
  196. B. Tareen, G. Godoy, and S. S. Taneja, “Focal therapy: a new paradigm for the treatment of prostate cancer,” Reviews in Urology, vol. 11, no. 4, pp. 203–212, 2009. View at Google Scholar
  197. K. F. Sullivan and E. D. Crawford, “Targeted focal therapy for prostate cancer: a review of the literature,” Therapeutic Advances in Urology, vol. 1, no. 3, pp. 149–159, 2009. View at Google Scholar